¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"genes, neurofibromatosis 2"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® neurofibromatosis ÇÑ±Û ½Å°æ¼¶À¯Á¾Áõ
¼³¸í   
  Àü½ÅÀÇ ¿©·¯°÷¿¡ ¹«´õ±â·Î ³ª´Â ½Å°æ¼¶À¯Á¾À» Æ¯Â¡À¸·Î Çϴ À¯Àü¼º Àü½Å º´. ¸»ÃÊ ½Å°æ»Ó ¾Æ´Ï¶ó ÁßÃß ½Å°æ°èµµ Ä§¹üÇÒ ¼ö ÀÖ´Ù. ½Å°æ¼¶À¯Á¾Àº ÁַΠÀü½ÅÀÇ ÇǺο¡ ¹ß»ýµÇÁö¸¸ ½Å°æ¾ó±â È¤Àº ³»Àå¿¡ »ý±â´Â ¼öµµ ÀÖ´Ù. ÇǺο¡´Â ¶ÇÇÑ °÷°÷¿¡ Æ¯À¯ÀÇ °¥»ö»ö¼Ò¹ÝÀ» º¸°Ô µÈ´Ù. °ñ°ÝÀÇ º¯ÇüÀ» ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. ½Å°æÃÊÁ¾À̳ª ¾Ç¼º½Å°æÃÊÁ¾, ´õ¿íÀÌ ½Å°æ±³Á¾À̳ª ¼ö¸·Á¾ µîÀÇ µÎ°³³»Á¾¾çÀ» ÇÕº´ÇÔµµ ¾Ë·ÁÁ® ÀÖ´Ù. 1Çü(von Recklinghausen º´, ÀüÇüÀû ½Å°æ¼¶À¯Á¾Áõ)°ú 2Çü(ÁßÃßÇü ¶Ç´Â Ã»°¢½Å°æ¼¶À¯Á¾Áõ)À¸·Î ±¸ºÐÇÑ´Ù. ÀüÇüÀû ½Å°æ¼¶À¯Á¾Áõ(1Çü)ÀÌ °¡Àå ¸¹ÀÌ ¹ß»ýÇϸ破ÙÀ½°ú °°Àº 3°¡Áö ¼Ò°ßÀ» º¸Àδô. Áï ¨ç Ã¼Ç¥¸é, Ã¼³» ¿©·¯ °÷¿¡ »êÀçµÇ¾î ¹ß»ýÇϴ ¾ó±â¸ð¾ç½Å°æÁ¾, ¨è ¿ìÀ¯Ä¿ÇǹÝÁ¡, ¨é ¸®½¬(Lisch) °áÀý·Î ºÒ¸®´Â È«Ã¤ÀÇ Âø»ö°ú¿ÀÁ¾ÀÌ´Ù. 2ÇüÀº 1Çüº¸´Ù ¹ß»ýºóµµ°¡ Àû°í, Æ¯Â¡ÀûÀ¸·Î ¾çÂʼº Ã»°¢½Å°æÁ¾ÀÌ ÀÖÀ¸¸ç, ¿ìÀ¯¹ÝÁ¡Àº º¸À̳ª ¸®½¬°áÀýÀº ¾ø´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • caretaker genes
    °ü¸®À¯ÀüÀÚ
  • homologous genes
    »óµ¿À¯ÀüÀÚ
  • multiple neurofibromatosis
    ´Ù¹ß½Å°æ¼¶À¯Á¾Áõ
  • neurofibromatosis
    ½Å°æ¼¶À¯Á¾Áõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neurofibromatosis
    ½Å°æ¼¶À¯Á¾Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • multiple neurofibromatosis
    ´Ù¹ß½Å°æ¼¶À¯Á¾Áõ
  • neurofibromatosis
    ½Å°æ¼¶À¯Á¾Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hox genes
    Ȥ½º À¯ÀüÀÚ, Hox À¯ÀüÀÚ
  • Von Recklinghausens disease(neurofibromatosis)
    Æù·¹Å¬¸µÇÏ¿ìÁ¨º´<½Å°æ¼¶À¯Á¾Áõ>.
  • acoustic neurofibromatosis
    û½Å°æ¼¶À¯Á¾Áõ(¡­àéë«ðþñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acoustic neurofibromatosis
    û½Å°æ¼¶À¯Á¾Áõ(¡­àéë«ðþñø)
  • multiple neurofibromatosis
    ´Ù¹ß½Å°æ¼¶À¯Á¾ Áõ(ÒýÛ¡ãêÌèàéë«ðþñø).
  • multiple neurofibromatosis
    ´Ù¹ß½Å°æ¼¶À¯Á¾Áõ(¡­ãêÌèàéë«ðþñø)
  • multiple neurofibromatosis
    ´Ù¹ß½Å°æ¼¶À¯Á¾Áõ(ÒýÛ¡ãêÌèàéë«ðþñø)
  • neurofibromatosis
    ½Å°æ¼¶À¯Á¾Áõ(¡­ñø) ·ºÅ¬¸µÇÏ¿ìÁ¨º´(¡­Ü»)
  • neurofibromatosis
    ½Å°æ¼¶À¯Á¾Áõ,·ºÅ¬¸µÇÏ¿ìÁ¨º´
  • c2 genes
    C2 À¯ÀüÀÚ (¡­ë¶îîí­)
  • cancer suppressor genes
    ¾Ï¾ïÁ¦À¯ÀüÀÚ(äßåäð¤ë¶îîí­)
  • ced genes
    ced À¯ÀüÀÚ(¡­ë¶îîí­)
  • complementary genes
    »óº¸¼ºÀ¯ÀüÀÚ(ßÀÜÍàõë¶îîí­).
  • cooperating genes
    Çùµ¿À¯ÀüÀÚ
  • fcc genes
    FCC À¯ÀüÀÚ
  • hox genes
    Ȥ½º À¯ÀüÀÚ, Hox À¯ÀüÀÚ
  • multiple genes
    ´ÙÀ¯ÀüÀÚ.
  • multiple genes
    º¹¼öÀ¯ÀüÀÚ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • C genes
    C À¯ÀüÀÚ(ë¶îîí­)
  • complementary genes
    »óº¸¼º À¯ÀüÀÚ(ßÓÜÍàõë¶îîí­)
  • housekeeping genes
    »ì¸² À¯ÀüÀÚ(ë¶îîí­)
  • J genes
    J À¯ÀüÀÚ(ë¶îîí­)
  • joining genes
    Á¢ÇÕÀ¯ÀüÀÚ(ïÈùêë¶îîí­)
  • luxury genes
    ƯȰÀ¯ÀüÀÚ(÷åüÀë¶îîí­)
  • reiterated genes
    ¹Ýº¹ À¯ÀüÀÚ(ÚãÜÖë¶îîí­)
  • syn genes
    ½Å À¯ÀüÀÚ(ë¶îîí­)
  • syntenic genes
    µ¿¿°»öü À¯ÀüÀÚ(ÔÒæøßäô÷ë¶îîí­)
  • two-genes-one-polypeptide chain
    ÀÌÀ¯ÀüÀÚ(ì£ë¶îîí­)- ÀÏ(ìé)Æú¸®ÆéŸÀÌµå »ç½½
  • ur genes
    ¿ø(ê«) À¯ÀüÀÚ
  • variable genes
    °¡º¯ºÎÀ§(ʦܨݻêÈ) À¯ÀüÀÚ (ë¶îîí­)
  • V genes
    V À¯ÀüÀÚ (ë¶îîí­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neurofibromatosis
    ½Å°æ¼¶À¯Á¾¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NF nafcillin; National Formulary; nephritic factor; neurofibromatosis; neurofilament; neutral fraction;...
NF1 neurofibromatosis type I; nuclear factor 1
NF2 neurofibromatosis type II
NFNS neurofibromatosis-Noonan syndrome
NPDC neurofibromatosis-pheochromocytoma-duodenal carcinoid [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ISG IFN stimulated genes
mdr Multidrug resistance genes
stx Shiga toxin genes
or genes gene
rDNA ribosomal DNA genes
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acoustic neurofibromatosis
    û½Å°æ ¼¶À¯Á¾Áõ
  • multiple neurofibromatosis
    ´Ù¹ß ½Å°æ ¼¶À¯Á¾Áõ
  • neurofibromatosis
    ½Å°æ ¼¶À¯Á¾Áõ, ½Å°æ ¼¶À¯Á¾
    ½Å°æ°è, ±ÙÀ°, »À ¹× ÇǺÎÀÇ ¹ßÀ° º¯È­¸¦ Ư¡À¸·Î ÇÏ´Â °¡Á·¼º ÁúȯÀ¸·Î¼­ »ö¼Ò Ä§Âø ºÎÀ§¸¦ µ¿¹ÝÇÑ Àü½Å¿¡ ºÐÆ÷µÈ ´Ù¹ß¼º À¯°æ¼º ¿¬Á¾¾çÀÇ Çü¼º¿¡ ÀÇÇØ¼­ ¿ÜºÎ¿¡¼­ ¾Ë ¼ö ÀÖ´Ù.
  • Recklinghausen's neurofibromatosis
    Recklinghausen ½Å°æ ¼¶À¯Á¾
    ½Å°æ°è, ±ÙÀ°, »À ¹× ÇǺÎÀÇ ¹ßÀ° º¯È­¸¦ Ư¡À¸·Î ÇÏ´Â °¡Á·¼º ÁúȯÀ¸·Î¼­, »ö¼Ò Ä§Âø ºÎÀ§¸¦ µ¿¹ÝÇÑ Àü½Å¿¡ ºÐÆ÷µÈ ´Ù¹ß¼º À¯°æ¼º ¿¬Á¾¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
genes, neurofibromatosis 2 Tumour suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes neurofibromatosis 2.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
genes, neurofibromatosis 1 Tumour suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. Mutation of these genes is thought to cause neurofibromatosis 1.
(12 Dec 1998)
abortive neurofibromatosis incomplete neurofibromatosis
central type neurofibromatosis Type I neurofibromatosis.
Incomplete neurofibromatosis, multiple neurofibromas with minimal manifestations, perhaps limited to cafe-au-lait spots; individuals with minimal lesions may have offspring with severe involvement.
Synonym: abortive neurofibromatosis.
(05 Mar 2000)
neurofibromatosis <oncology> One of the most common disorders in genetics, neurofibromatosis encompasses at least two diseases, designated NF-1 and NF-2.
NF-1 or classic neurofibromatosis, is characterised by the familiar cafe- au-lait spots, axillary freckling, cutaneous and visceral neurofibromas (which sometimes undergo malignant transformation), gliomas, scoliosis, and Lisch nodules of the iris. NF-1 is associated with the the von Recklinghausen Neurofibromatosis locus that encodes the NF-1 protein, a GTPase activating protein which interacts with the ras proteins. The gene is located on chromosome 17.
NF-2, also called acoustic or central neurofibromatosis, features neurofibromas restricted to the acoustic nerve (usually bilateral) and the central nervous system, skin lesions may or may not be present. The gene is located on chromosome 22.
There are no biochemical markers of the disorder, but the cloning of both the NF-1 and NF-2 genes makes DNA-based diagnosis possible in some families. Both genes appear to be tumour suppressor genes. Both conditions are autosomal dominant, but the variable penetrance and expressivity and high frequency of new mutations make genetic counseling difficult.
Inheritance: autosomal dominant.
(29 Dec 1997)
neurofibromatosis 1 A congenital autosomal dominant disorder characterised by developmental changes in the nervous system, muscles, bones, and skin especially in those derived from the embryonic neural crest. There are multiple cutaneous tumours and tumours of the peripheral and central nervous system. The disease has been linked to mutations of the nf1 gene on chromosome 17.
(12 Dec 1998)
neurofibromatosis 2 Severe autosomal dominant disorder characterised especially by bilateral acoustic neuromas as well as other multiple tumours including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the nf2 gene on chromosome 22.
(12 Dec 1998)
breast cancer susceptibility genes Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered.
(12 Dec 1998)
cancer, breast, susceptibility genes Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered.
(12 Dec 1998)
genes Located in the nucleus of the cell, genes contain hereditary information that is transferred from cell to cell.
(09 Oct 1997)
genes, abl Retrovirus-associated DNA sequences (abl) originally isolated from the abelson murine leukaemia virus (ab-mulv). The proto-oncogene abl (c-abl) codes for a protein that is a member of the tyrosine kinase family. The human c-abl gene is located at 9q34.1 on the long arm of chromosome 9. It is activated by translocation to bcr on chromosome 22 in chronic myelogenous leukaemia.
(12 Dec 1998)
genes, apc Tumour suppressor genes located in the 5q21 region on the long arm of chromosome 5. The mutation of these genes is associated with familial adenomatous polyposis (apc stands for adenomatous polyposis coli) and gardner's syndrome, as well as some sporadic colourectal cancers.
(12 Dec 1998)
genes, arac Regulatory genes which encode a cyclic AMP receptor protein required for l-arabinose utilization in e. Coli. It is an example of positive control or regulation of gene expression in the bacterial operon.
(12 Dec 1998)
genes, archaeal The genetic material of archaea.
(12 Dec 1998)
genes, bacterial The genetic material of bacteria.
(12 Dec 1998)
genes, bcl-1 The B-cell leukaemia/lymphoma-1 genes, associated with various neoplasms when overexpressed. Overexpression results from the t(11;14) translocation, which is characteristic of mantle zone-derived B-cell lymphomas. The human c-bcl-1 gene is located at 11q13 on the long arm of chromosome 18.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Genes, Neurofibromatosis 2 - »õâ Tumor suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes NEUROFIBROMATOSIS 2.
    Synonyms : Genes, nf 2, Gene, Neurofibromatosis 2, Gene, nf 2, Gene, nf2, Neurofibromatosis 2 Gene, nf 2 Gene, nf 2 Genes, nf2 Gene
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á